Evidence map›Paper›PMID 37389412›Full record

ArticlemSphere2023

Development of the

K Ross Turbyfill, Kristen A Clarkson, Edwin V Oaks, Daniel V Zurawski, Anthony R Vortherms, Robert W Kaminski

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. BECC-engineered live-attenuatedResearch square · 2024
    Article
  6. International journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

K Ross TurbyfillDepartment of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research , Silver Spring, Maryland, USA.ORCID 0000-0002-7495-0370
Kristen A ClarksonDepartment of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research , Silver Spring, Maryland, USA.
Edwin V OaksPatuxent Research and Consulting Group , Gambrills, Maryland, USA.
Daniel V ZurawskiWound Infections Department, Bacterial Diseases Branch, Walter Reed Army Institute of Research , Silver Spring, Maryland, USA.
Anthony R VorthermsDepartment of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research , Silver Spring, Maryland, USA.
Robert W KaminskiDepartment of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research , Silver Spring, Maryland, USA.
Walter Reed Army Institute of Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Indexed as

ShigellaShigella VaccinesVaccinesChildHumansLipopolysaccharidesShigella flexneriLipopolysaccharidesShigella VaccinesVaccinesefficacyimmunogenicityInvaplexShigellavaccine

Identifiers

PMID37389412
PMCPMC10449495
OpenAlexW4382631816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.